ACC American College of Cardiology, AHA American Heart Association, ESC European Society of Cardiology, ADA American Diabetes Association, GLP-1 RA glucagon-like peptide 1 receptor agonists, T2DM type 2 diabetes mellitus, ASCVD atherosclerotic cardiovascular disease, CV cardiovascular, CVD cardiovascular disease, MACE major adverse cardiovascular event, SGLT2i sodium-glucose co-transporter 2 inhibitors, BMI body mass index, MI myocardial infarction, HFpEF heart failure with preserved ejection fraction a ACC/AHA and ESC utilize class of recommendation (1, 2a, 2b, 3) which highlights the overall benefit of a treatment compared to its risks
Research shows that approximately 12 percent of patients pause or discontinue GLP-1 treatment due to digestive discomfort
His glutes and quads were no longer handling impact forces as effectively, which changed how he moved and tolerated training loads
Frequently asked questions A medically assisted weight loss program may be right for you if you: Have a BMI of 30 or higher Have a BMI of 27 or higher with a chronic condition related to your weight Have struggled to lose weight through diet and exercise alone Your Fast Pace Health provider will determine eligibility and help ensure treatment is appropriate for you
The medications are not interchangeable milligram-for-milligram
